GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prevest Denpro Ltd (BOM:543363) » Definitions » EBIT

Prevest Denpro (BOM:543363) EBIT : ₹234.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Prevest Denpro EBIT?

Prevest Denpro's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ₹58.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹234.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Prevest Denpro's annualized ROC % for the quarter that ended in Dec. 2024 was 35.58%. Prevest Denpro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 64.63%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Prevest Denpro's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 4.51%.


Prevest Denpro EBIT Historical Data

The historical data trend for Prevest Denpro's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prevest Denpro EBIT Chart

Prevest Denpro Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial 64.53 95.22 161.56 209.57 214.32

Prevest Denpro Quarterly Data
Mar19 Mar20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.35 63.75 49.03 63.78 58.18

Competitive Comparison of Prevest Denpro's EBIT

For the Medical Instruments & Supplies subindustry, Prevest Denpro's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prevest Denpro's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prevest Denpro's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Prevest Denpro's EV-to-EBIT falls into.


;
;

Prevest Denpro EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹234.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prevest Denpro  (BOM:543363) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Prevest Denpro's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=189.156 * ( 1 - 22.2% )/( (413.603 + 0)/ 1 )
=147.163368/413.603
=35.58 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1026.667 - 15.725 - ( 597.339 - max(0, 59.221 - 762.258+597.339))
=413.603

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Prevest Denpro's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=232.712/( ( (264.409 + max(95.653, 0)) + (0 + max(0, 0)) )/ 1 )
=232.712/( ( 360.062 + 0 )/ 1 )
=232.712/360.062
=64.63 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(68.786 + 67.088 + 19) - (15.725 + 0 + 43.496)
=95.653

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Prevest Denpro's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=234.735/5200.110
=4.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prevest Denpro EBIT Related Terms

Thank you for viewing the detailed overview of Prevest Denpro's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Prevest Denpro Business Description

Traded in Other Exchanges
N/A
Address
EPIP, Kartholi, Bari Brahmana, Samba, Jammu & Kashmir, HP, IND, 181133
Prevest Denpro Ltd develops, manufactures and markets a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The company's product portfolio covers wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.

Prevest Denpro Headlines

No Headlines